{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:13:53Z","timestamp":1787804033933,"version":"build-2784847793"},"reference-count":48,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Seizure emergencies experienced by patients with epilepsy include status epilepticus and seizure clusters. Although an accepted definition of status epilepticus exists, no clear consensus definition of seizure clusters has emerged; this is further complicated by the appearance in the literature of various empirically based definitions that have been developed for clinical trial study designs. In general, patients with intractable epilepsy have been shown to have a significant risk for acute episodes of increased seizure activity called seizure clusters (also referred to as acute repetitive seizures, among other terms) that differ from their usual seizure pattern. Duration (e.g., number of hours or days) is often included in the definition of a seizure cluster; however, the duration may vary among patients, with some seizure clusters lasting \u226524\u2009h and requiring long\u2010acting treatment for this period. In addition to seizure cluster duration, the time between seizures and possible acceleration in seizure frequency during the cluster may be important variables. The recognition and treatment of seizure clusters require urgent action because episodes that are not quickly and appropriately treated may lead to injury or progress to status epilepticus or potentially death. Most seizure clusters occur outside a medical facility (in the community) and treatment is usually administered by nonmedical individuals; therefore, health care providers may benefit from a clear description of these potential seizure emergencies that they can then use to educate patients and caregivers on the prompt and appropriate identification of seizure clusters and administration of rescue therapy. Here we explore why greater uniformity is needed in the discussion of seizure clusters. This exploration examines epidemiologic studies of seizure clusters and status epilepticus, inconsistencies in nomenclature and definitions for seizure clusters, practical application of seizure cluster terminology, and the potential use of acute seizure action plans and patient\u2010specific individualized definitions in the clinical setting.<\/jats:p>","DOI":"10.1111\/epi.17346","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T02:11:10Z","timestamp":1661307070000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Recognizing seizure clusters in the community: The path to uniformity and individualization in nomenclature and definition"],"prefix":"10.1111","volume":"63","author":[{"given":"Sheryl R.","family":"Haut","sequence":"first","affiliation":[{"name":"Comprehensive Epilepsy Management Center Einstein\u2010Montefiore  Bronx New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5877-4074","authenticated-orcid":false,"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[{"name":"Reference Center for Rare Epilepsies, Department of Pediatric Neurology, H\u00f4pital Necker Enfants Malades, APHP, EPICARE European Reference Network Universit\u00e9 de Paris Cit\u00e9, Institut Imagine, Inserm U1163  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"Epilepsy Foundation of America.Is this a seizure?. Available from:https:\/\/www.epilepsy.com\/learn\/diagnosis\/seizure. Accessed 14 Dec 2021."},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2018.02.032"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13291"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000177"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1981.tb06159.x"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.107836"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2020.106330"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.05.013"},{"key":"e_1_2_12_10_1","unstructured":"World Health Organization.Epilepsy. Available from:https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/epilepsy. Accessed 26 Aug 2021."},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2015.11.003"},{"key":"e_1_2_12_12_1","unstructured":"Centers for Disease Control and Prevention.Epilepsy data and statistics. Available from:https:\/\/www.cdc.gov\/epilepsy\/data\/index.html. Accessed April 22 2019."},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2005.08.018"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14596"},{"key":"e_1_2_12_15_1","unstructured":"US Food and Drug Administration.Orphan indications: diazepam (intranasal). Available from:https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=382512. Accessed 7 Dec 2021."},{"key":"e_1_2_12_16_1","unstructured":"US Food and Drug Administration.Orphan drug act \u2010\u2010 revelvant excerpts. Available from:https:\/\/www.fda.gov\/industry\/designating\u2010orphan\u2010product\u2010drugs\u2010and\u2010biological\u2010products\/orphan\u2010drug\u2010act\u2010relevant\u2010excerpts. Accessed 23 Sep 2021."},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2017.04.016"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2005.29004.x"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2009.08.006"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2017.05.037"},{"key":"e_1_2_12_21_1","unstructured":"Epilepsy Foundation.PCDH19 epilepsy. Available from:https:\/\/www.epilepsy.com\/learn\/epilepsy\u2010due\u2010specific\u2010causes\/genetic\u2010causes\u2010epilepsy\/specific\u2010genetic\u2010epilepsies\/pcdh19\u2010epilepsy. Accessed 5 Nov 2021."},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/21556660.2021.1962671"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2015.04.022"},{"key":"e_1_2_12_24_1","unstructured":"European Medicines Agency.Buccolam. Available from:https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/buccolam. Accessed 3 Sep 2021."},{"key":"e_1_2_12_25_1","unstructured":"National Institute for Health and Care Excellence.Epilepsies: diagnosis and management: clinical guideline CG137. National Institute for Health and Care Excellence; 11 January2021."},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2016.01.028"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806253382602"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0000000000000140"},{"key":"e_1_2_12_29_1","unstructured":"Epilepsy Foundation.Seizure triggers in children. Available from:https:\/\/www.epilepsy.com\/living\u2010epilepsy\/parents\u2010and\u2010caregivers\/about\u2010kids\/seizure\u2010triggers\u2010children. Accessed 5 Nov 2021."},{"key":"e_1_2_12_30_1","volume-title":"Diastat\u00ae C\u2010IV (diazepam rectal gel). Full prescribing information","author":"Bausch Health US, LLC","year":"2021"},{"key":"e_1_2_12_31_1","volume-title":"NAYZILAM\u00ae (midazolam nasal spray). Full prescribing information","author":"UCB, Inc","year":"2021"},{"key":"e_1_2_12_32_1","volume-title":"Valtoco (diazepam nasal spray). Full prescribing information","author":"Neurelis, Inc","year":"2021"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb02047.x"},{"key":"e_1_2_12_34_1","unstructured":"US Food and Drug Administration.Search orphan drug designatations and approvals. Available from:https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=61591. Accessed 3 Sep 2021."},{"key":"e_1_2_12_35_1","volume-title":"Diastat\u00ae (diazepam rectal gel rectal delivery system). Full prescribing information","author":"Valeant Pharmaceuticals","year":"2016"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.15159"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17041"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-019-0164-x"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.2012.617"},{"key":"e_1_2_12_40_1","unstructured":"Electronic Medicines Compendium.Diazepam Desitin 5\u2009mg rectal solution. Available from:https:\/\/www.medicines.org.uk\/emc\/product\/2997\/smpc. Accessed 8 Sep 2021."},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13465"},{"key":"e_1_2_12_42_1","unstructured":"LGS Foundation.Seizure clusters and status epilepticus in LGS. Available from:https:\/\/www.lgsfoundation.org\/seizure\u2010clusters\u2010and\u2010status\u2010epilepticus\u2010in\u2010lgs\/. Accessed 7 Sep 2021."},{"issue":"1","key":"e_1_2_12_43_1","first-page":"S25","article-title":"Introduction to use of an acute seizure action plan for seizure clusters and guidance for implementation","volume":"63","author":"Patel AD","year":"2022","journal-title":"Epilepsia"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108264"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.5.1274"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb01607.x"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.4065\/84.6.495"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000623"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16300"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.17346","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/epi.17346","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.17346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T20:04:13Z","timestamp":1692734653000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/epi.17346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":48,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1111\/epi.17346"],"URL":"https:\/\/doi.org\/10.1111\/epi.17346","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"2022-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}